Embolization in pelvic venous disorders using ethylene vinyl alcohol copolymer (Onyx®) and Aetoxysclerol: a prospective evaluation of safety and long-term efficacy
- PMID: 35137302
- DOI: 10.1007/s00330-022-08567-z
Embolization in pelvic venous disorders using ethylene vinyl alcohol copolymer (Onyx®) and Aetoxysclerol: a prospective evaluation of safety and long-term efficacy
Abstract
Objectives: To prospectively evaluate the safety and efficacy of embolization using ethylene vinyl alcohol copolymer (Onyx®) and Aetoxysclerol for treatment of pelvic venous disorders (PeVD).
Methods: This prospective study was approved by the institutional ethics review board. Ten clinical parameters were retained for evaluation of PeVD (pelvic pain, dyspareunia, post-coital pain, menstruation pain, lower limbs pain, difficulty walking, aesthetic discomfort, impact on daily working life, psychological impact and impact on daily life), measured on a visual analogue scale (VAS) between 0 and 10, and a global score out of 100 was noted before embolization, after 3 months during the imaging follow-up, and at the end of follow-up by phone call. The main criterion was clinical efficacy of embolization defined by an impairment score < 40/100 and a 50% decrease in overall score. Complications were recorded. Visualization of Onyx® on MRI 3 months after embolization was noted.
Results: Between July 2017 and May 2019, 73 consecutive women (mean age ± SD [range]: 41 ± 11 years [25-77]) treated by embolization with Onyx® and Aetoxysclerol were included. The median follow-up was 28 months [Q1-Q3: 24.0-29.2] (range: 18.1-34.5). The median initial VAS impairment score was 39/100 [29.75-48.50] (12-58). Clinical efficacy was obtained for 70 patients (70/73, 95.9%), and the median VAS impairment score at the end of follow-up was significantly lower at 3 [0.00-7.25] (0-73) (p < 0.0001). Four minor complications occurred. Onyx® was visualized on DIXON sequence of MRI for all patients.
Conclusion: Embolization using Onyx® and Aetoxysclerol for PeVD is safe and effective.
Key points: • Embolization using Onyx® and Aetoxysclerol for pelvic venous disorders is safe and effective. • Imaging follow-up is facilitated by visualization of Onyx® on MRI DIXON sequences.
Keywords: Aetoxysclerol; Onyx® copolymer; Varicose veins; Venous congestion; Venous insufficiency.
© 2022. The Author(s), under exclusive licence to European Society of Radiology.
References
-
- Gültaşli NZ, Kurt A, Ipek A et al (2006) The relation between pelvic varicose veins, chronic pelvic pain and lower extremity venous insufficiency in women. Diagn Interv Radiol 12(1):34–38 - PubMed
-
- Phillips D, Deipolyi AR, Hesketh RL, Midia M, Oklu R (2014) Pelvic congestion syndrome: etiology of pain, diagnosis, and clinical management. J Vasc Interv Radiol. https://doi.org/10.1016/j.jvir.2014.01.030
-
- Greiner M, Gilling-Smith GL (2007) Leg varices originating from the pelvis: diagnosis and treatment. Vascular. https://doi.org/10.2310/6670.2006.00030
-
- Bora A, Avcu S, Arslan H, Adali E, Bulut MD (2012) The relation between pelvic varicose veins and lower extremity venous insufficiency in women with chronic pelvic pain. JBR-BTR. https://doi.org/10.5334/jbr-btr.623
-
- Khilnani NM, Meissner MH, Learman LA et al (2019) Research priorities in pelvic venous disorders in women: recommendations from a multidisciplinary research consensus panel. J Vasc Interv Radiol. https://doi.org/10.1016/j.jvir.2018.10.008 Epub 2019 Mar 8
MeSH terms
Substances
LinkOut - more resources
Miscellaneous